Oral

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers…
Read More...

Laryngeal dystonia (LD), a rare neurological disease that significantly impacts a person's ability to speak due to uncontrollable vocal cord spasms, can have a debilitating effect on a person's social life, employment and…
Read More...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions. Associate Professor…
Read More...

if (g_displayableSlots.mobileTopLeaderboard) { pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); }); } BMJ GroupNov 20 2024 The number and type of microbes present in the saliva…
Read More...

if (g_displayableSlots.mobileTopLeaderboard) { pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); }); } University of GothenburgNov 15 2024 Healthcare workers at nursing homes…
Read More...

Lifestyle can shape the composition of beneficial bacteria and other microorganisms within the mouth, according to a new study led by Penn State biologists. The international team revealed how the "oral microbiome" differs…
Read More...

Source link : News-Medica
Read More...

As global aging accelerates, a new study highlights how oral health deterioration affects older adults and calls for integrated healthcare solutions to improve their quality of life. Review: Healthy ageing and oral health:…
Read More...

A recent study published in the journal Diabetes Therapy discusses the results of the PIONEER REAL study conducted in the Netherlands, which evaluated the efficacy of oral semaglutide in managing type 2 diabetes and supporting…
Read More...